key: cord-0729088-k3op89b2
authors: Torres, Jaime R
title: Sequential Dengue and Covid-19. A case of viral Dr. Jekyll or Mr. Hyde?
date: 2021-07-10
journal: Clin Infect Dis
DOI: 10.1093/cid/ciab620
sha: d262fb3ac52eac5913f9f50b9c9f8c3505f9f6bd
doc_id: 729088
cord_uid: k3op89b2

nan

A c c e p t e d M a n u s c r i p t Although the authors duly acknowledge some of the limitations of the study, not enough consideration is given to the possibly that the same socio-demographic factors present in the population most exposed to dengue, might precisely favor the risk of falling sicker for those infected by SARS-CoV-2, in a syndemic but indirect manner. On the other hand, while a claim is made that prior dengue infection would induce a more symptomatic Covid-19 illness, suggesting a potential role for an antibody dependent-like enhancement mechanism, no data is provided about the level of preexisting anti-DENV antibodies of the subjects studied, or its temporality. Of note, antibody titer does predict enhancement of severe dengue disease in humans. 2 However, the correlate of risk for severe dengue disease (a DENV-Ab titer 1:21 to 1:80) is distinct from the correlate of protection (DENVAb titers above 1:320) against symptomatic dengue. 2 It is conceivable that an analogous situation may be the case for DENV/SARS-Cov-2 consecutively infected patients, also.

Finally, in view of contradictory available epidemiological and laboratory evidence, as well as the antigenic cross-reactivity between DENV and SARS-Cov-2, 1, 3-5 numerous questions remain regarding the possibility of either protective immunity mechanisms overlapping M a n u s c r i p t between these 2 diseases, or increased risk of severe illness through antibody dependentlike enhancement, after a sequential infection. These unresolved issues, which carry important public health implications, need to be addressed in future studies.

The author has no potential conflicts.

Interacting Epidemics in Amazonian Brazil: Prior Dengue Infection Associated with Increased COVID-19 Risk in a Population-Based Cohort Study

Antibody-dependent enhancement of severe dengue disease in humans

Previous Dengue Infection and Mortality in Coronavirus Disease 2019 (COVID-19)

Potential Antigenic Cross-reactivity Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Dengue Viruses

The impact of superspreader cities, highways, and intensive care availability in the early stages of the COVID-19 epidemic in Brazil

A c c e p t e d M a n u s c r i p t